ArticleOphthalmology and therapy2026
Synergising Macular Function and Structure in Diabetic Macular Oedema to Improve Patient Care: An International Delphi Consensus.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe correlation between diabetic macular oedema (DMO) structural and functional assessments and their reflection of patient impact lacks consensus. This study aims to understand the ophthalmology community's thoughts on optimising patient care by improving functional and structural assessments.
methodsThe process employed a modified Delphi methodology. Following a literature review, a steering committee of six experts developed 40 statements under three consensus topics. The statements were globally distributed via an online, four-point Likert scale survey using a snowball sampling technique.
resultsSurvey responses (n = 93) were collated anonymously and independently analysed. Consensus was achieved in 35 statements (88%). There was strong agreement that routinely used assessments for DMO may not accurately reflect the level of vision impairment experienced by the patient and that there is a need for a composite functional assessment (of two or more tests) to demonstrate better correlation with structural changes. The correlation of anatomical features like central subfield thickness, epiretinal membrane, intraretinal fluid, and subretinal fluid volumes with visual acuity outcomes remain uncertain.
conclusionThis consensus supports the need to develop a composite assessment to improve patient care. Utilising contrast sensitivity, distance and near low luminance, and novel patient-reported outcome measures may improve patient-centric assessments to better understand the patient's quality of life and functional experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.